Insulet Current Ratio 2007-2020 | PODD

Current and historical current ratio for Insulet (PODD) from 2007 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Insulet current ratio for the three months ending March 31, 2020 was 4.15.
Insulet Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.54B $0.13B 4.15
2019-12-31 $0.59B $0.16B 3.75
2019-09-30 $0.79B $0.11B 7.01
2019-06-30 $0.50B $0.11B 4.72
2019-03-31 $0.50B $0.11B 4.36
2018-12-31 $0.46B $0.12B 3.99
2018-09-30 $0.45B $0.10B 4.58
2018-06-30 $0.42B $0.08B 5.54
2018-03-31 $0.45B $0.08B 5.48
2017-12-31 $0.54B $0.09B 6.24
2017-09-30 $0.37B $0.08B 4.88
2017-06-30 $0.34B $0.05B 7.06
2017-03-31 $0.34B $0.04B 8.56
2016-12-31 $0.37B $0.06B 6.64
2016-09-30 $0.36B $0.05B 6.67
2016-06-30 $0.18B $0.06B 3.29
2016-03-31 $0.17B $0.05B 3.45
2015-12-31 $0.19B $0.07B 2.93
2015-09-30 $0.19B $0.06B 3.27
2015-06-30 $0.20B $0.05B 3.87
2015-03-31 $0.21B $0.05B 4.34
2014-12-31 $0.21B $0.04B 4.70
2014-09-30 $0.21B $0.05B 4.33
2014-06-30 $0.23B $0.07B 3.26
2014-03-31 $0.20B $0.04B 4.64
2013-12-31 $0.20B $0.04B 4.68
2013-09-30 $0.20B $0.05B 4.14
2013-06-30 $0.20B $0.03B 5.82
2013-03-31 $0.20B $0.04B 4.53
2012-12-31 $0.11B $0.05B 2.28
2012-09-30 $0.11B $0.05B 2.32
2012-06-30 $0.12B $0.04B 2.70
2012-03-31 $0.13B $0.03B 3.94
2011-12-31 $0.13B $0.03B 4.74
2011-09-30 $0.14B $0.03B 5.57
2011-06-30 $0.15B $0.03B 5.56
2011-03-31 $0.13B $0.02B 7.95
2010-12-31 $0.14B $0.02B 7.52
2010-09-30 $0.13B $0.02B 6.52
2010-06-30 $0.15B $0.02B 6.13
2010-03-31 $0.14B $0.02B 7.93
2009-12-31 $0.15B $0.02B 7.79
2009-09-30 $0.10B $0.02B 5.48
2009-06-30 $0.08B $0.02B 4.79
2009-03-31 $0.10B $0.02B 5.05
2008-12-31 $0.09B $0.02B 5.22
2008-09-30 $0.11B $0.02B 6.70
2008-06-30 $0.13B $0.02B 8.04
2008-03-31 $0.09B $0.03B 3.49
2007-12-31 $0.11B $0.02B 5.17
2007-09-30 $0.11B $0.02B 5.90
2007-06-30 $0.13B $0.02B 7.50
2007-03-31 $0.03B $0.04B 0.67
2006-12-31 $0.04B $0.04B 1.02
2006-09-30 $0.00B 0.00
2006-06-30 $0.00B 0.00
2006-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.912B $0.738B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $164.450B 28.52
Medtronic (MDT) Ireland $125.022B 20.31
Stryker (SYK) United States $68.931B 22.37
Boston Scientific (BSX) United States $49.803B 23.41
Baxter (BAX) United States $44.690B 27.28
Lonza Group Ag (LZAGY) Switzerland $41.166B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.427B 0.00
Terumo (TRUMY) Japan $29.067B 37.15
ResMed (RMD) United States $28.011B 44.21
Zimmer Biomet Holdings (ZBH) United States $24.370B 15.33
Sunny Optical Technology (SNPTF) China $20.368B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.450B 0.00
Bio-Rad Laboratories (BIO) United States $13.799B 62.81
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.894B 77.75
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Hill-Rom Holdings (HRC) United States $7.589B 21.39
Perrigo (PRGO) Ireland $7.537B 13.48
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.943B 0.00
Haemonetics (HAE) United States $4.645B 27.90
Neogen (NEOG) United States $4.121B 69.81
GW Pharmaceuticals (GWPH) United Kingdom $3.928B 0.00
ICU Medical (ICUI) United States $3.914B 28.56
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.812B 0.00
Agios Pharmaceuticals (AGIO) United States $3.779B 0.00
Envista Holdings (NVST) United States $3.471B 0.00
NuVasive (NUVA) United States $2.841B 22.82
National Vision Holdings (EYE) United States $2.436B 42.15
TG Therapeutics (TGTX) United States $2.253B 0.00
AtriCure (ATRC) United States $1.851B 0.00
MacroGenics (MGNX) United States $1.419B 0.00
NanoString Technologies (NSTG) United States $1.416B 0.00
Aurora Cannabis (ACB) Canada $1.379B 0.00
Aphria (APHA) Canada $1.253B 0.00
Cerus (CERS) United States $1.125B 0.00
Cardiovascular Systems (CSII) United States $1.093B 0.00
Phibro Animal Health (PAHC) United States $1.063B 21.19
Meridian Bioscience (VIVO) United States $1.046B 39.37
PetIQ (PETQ) United States $0.983B 28.39
InMode (INMD) Israel $0.969B 20.49
DFB Healthcare Acquisitions (AHCO) United States $0.935B 155.62
Zynex (ZYXI) United States $0.905B 90.90
Vapotherm (VAPO) United States $0.902B 0.00
Omeros (OMER) United States $0.813B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.783B 157.75
Eagle Pharmaceuticals (EGRX) United States $0.652B 46.69
VAREX IMAGING (VREX) United States $0.587B 14.57
Lantheus Holdings (LNTH) United States $0.584B 11.74
Surmodics (SRDX) United States $0.580B 69.90
LeMaitre Vascular (LMAT) United States $0.529B 30.13
Owens & Minor (OMI) United States $0.482B 12.75
BioLife Solutions (BLFS) United States $0.470B 164.36
Viemed Healthcare (VMD) United States $0.383B 33.97
Cytosorbents (CTSO) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.321B 23.34
HEXO (HEXO) $0.316B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.310B 0.00
Organigram Holdings (OGI) Canada $0.274B 0.00
Female Health (VERU) United States $0.222B 0.00
InfuSystems Holdings (INFU) United States $0.214B 118.44
Chimerix (CMRX) United States $0.199B 0.00
Bovie Medical (APYX) United States $0.182B 0.00
Evolus (EOLS) United States $0.179B 0.00
Surface Oncology (SURF) United States $0.173B 0.00
Exagen (XGN) United States $0.163B 0.00
Fonar (FONR) United States $0.136B 12.09
Rockwell Medical (RMTI) United States $0.132B 0.00
United Health Products (UEEC) United States $0.126B 0.00
Liberty Health Sciences (LHSIF) Canada $0.116B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.083B 0.00
Chembio Diagnostics (CEMI) United States $0.081B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.069B 16.11
Brainsway (BWAY) Israel $0.064B 0.00
Capricor Therapeutics (CAPR) United States $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.011B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00